Drug safety notice: Sevredol 10mg and 20mg tablets

July 14, 2021

We have been informed by Napp Pharmaceuticals Limited of a recent error regarding specific batches of Sevredol 10mg tablets and Sevredol 20mg tablets relating to differences in the patient information leaflets. The error identified relates to approved safety-related variations to the patient information leaflets that were not implemented, resulting in an older version of artwork being used and packed within finished batches.

Clinical colleagues must be mindful that patients may bring in affected batches from home and should be counselled appropriately and have an updated patient information leaflet which can be accessed by clicking here.

For further details including a list of batch numbers which have been affected, please see Sevredol 10mg and 20mg tablets information sheet.

For more information please contact the pharmacy department on ext. 5263/3783.